Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Current Deferred Revenue (2019 - 2025)

Cellebrite DI's Current Deferred Revenue history spans 7 years, with the latest figure at $277.6 million for Q4 2025.

  • Quarterly Current Deferred Revenue rose 5.86% to $277.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $277.6 million through Dec 2025, up 5.86% year-over-year, with the annual reading at $277.6 million for FY2025, 5.86% up from the prior year.
  • Current Deferred Revenue came in at $277.6 million for Q4 2025, up from $239.7 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $277.6 million in Q4 2025 to a low of $115.0 million in Q3 2021.
  • The 5-year median for Current Deferred Revenue is $185.0 million (2024), against an average of $187.6 million.
  • Year-over-year, Current Deferred Revenue skyrocketed 34.06% in 2023 and then increased 5.86% in 2025.
  • Cellebrite DI's Current Deferred Revenue stood at $159.4 million in 2021, then rose by 22.25% to $194.9 million in 2022, then grew by 24.6% to $242.8 million in 2023, then grew by 7.99% to $262.2 million in 2024, then increased by 5.86% to $277.6 million in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Current Deferred Revenue are $277.6 million (Q4 2025), $239.7 million (Q3 2025), and $227.2 million (Q2 2025).